Lorazepam and Hyperreflexia - a phase IV clinical study of FDA data
Summary:
Hyperreflexia is reported as a side effect among people who take Lorazepam (lorazepam), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Diazepam, and have Depression.
The phase IV clinical study analyzes which people have Hyperreflexia when taking Lorazepam. It is created by eHealthMe based on reports of 161,687 people who have side effects when taking Lorazepam from the FDA, and is updated regularly.
What is Lorazepam?
Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.
What is Hyperreflexia?
Hyperreflexia (overactive or over responsive reflexes) is found to be associated with 420 drugs and 651 conditions by eHealthMe. Check the latest studies of Hyperreflexia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
161,687 people reported to have side effects when taking Lorazepam.
Among them, 209 people (0.13%) have Hyperreflexia.

Among these 209 people:
How long have people been on Lorazepam when they have Hyperreflexia? *
What is the gender of people who have Hyperreflexia when taking Lorazepam? *
What is the age of people who have Hyperreflexia when taking Lorazepam? *
What are other drugs people take besides Lorazepam? *
What are other side effects people have besides Hyperreflexia? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Lorazepam and have Hyperreflexia?
- Check whether Hyperreflexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Lorazepam:
- Lorazepam (165,639 reports)
Hyperreflexia treatments and more:
- Hyperreflexia (4,677 reports)
How severe was Hyperreflexia and when was it recovered:
Expand to all the drugs that have ingredients of lorazepam:
- Hyperreflexia and drugs with ingredients of lorazepam (235 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lorazepam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hyperreflexia:
- Hyperreflexia (420 drugs)
Browse all the conditions that are associated with Hyperreflexia:
- Hyperreflexia (651 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lorazepam (the active ingredients of Lorazepam) and Lorazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Benadryl and Meloxicam drug interactions for women aged 50-59 - 10 seconds ago
- Vitamin D and Spironolactone drug interactions for men aged 50-59 - 17 seconds ago
- Could Apixaban cause White Blood Cell Count Increased? - 18 seconds ago
- Drug interactions of Stelazine and Ativan - 32 seconds ago
- Risperidone and Vimpat drug interactions for boys aged 10-19 - 38 seconds ago
- Could Skyrizi cause Coronary Artery Occlusion? - 53 seconds ago
- Hydroxyzine and Codeine drug interactions for women aged 20-29 - 53 seconds ago
- Could Paroxetine Hydrochloride cause Throat Irritation? - a minute ago
- Ondansetron and Fatigue Aggravated for Men aged 60+ - a minute ago
- Could Captopril cause Venous Thrombosis Limb? - a minute ago